Data behind the platform

Proof made understandable.

A dedicated evidence page gives partners and customers a clear view of what was tested, what was measured and what each result means.

View platform data
DNA strand in a molecular environment
32.3 nm Carrier D50 confirmed by Microtrac DLS
251 µg/cm² CBD permeated in the 16-hour model
60 / 40 Permeated delivery / skin-associated reservoir
100% Sub-dermal absorption reported in the tested model

Proven topical penetration

The test model at a glance.

Independent testing used CBD as the base active to characterize the carrier and delivery behavior.

Test

PAMPA / STRAT-M contact model

Duration

16-hour exposure window

Independent lab

Sunny BioDiscovery, Inc.

Carrier sizing

Microtrac DLS, D50

Visualization of active penetration through skin layers
60% permeated into the tested receiving layer
40% remained associated as a potential reservoir

Clinical review

Visible change, carefully framed.

The deck documents four Solaura cases after 20 days of use, with matched lighting and framing and independent dermatological review by Dr. Steven Shapiro, MD.

Documented Solaura eye-area case Case 01 · 42-year-old woman
Documented Solaura facial case Case 02 · 63-year-old woman
Documented Solaura eye-area case Case 04 · 26-year-old woman

Photography and efficacy statements are presented as supplied in the GWbiohealth partner deck and require final legal/regulatory review before public publication.

Website content strategy

Claims stay connected to context.

The redesign avoids scattering scientific numbers as decoration. Each metric is paired with the tested active, model, duration and responsible source—making the site more credible and easier to review.